MYELODYSPLASTIC NEOPLASMS

Clinical trials for MYELODYSPLASTIC NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC NEOPLASMS trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough blood cancers: experimental drug JNJ-90189892 enters human testing

Disease control Recruiting now

This early-stage trial is testing an experimental drug called JNJ-90189892 in about 155 people with acute myeloid leukemia (AML) or myelodysplastic neoplasms (MDS) that have come back or not responded to treatment. The study has several parts: first, finding a safe dose of JNJ-90…

Matched conditions: MYELODYSPLASTIC NEOPLASMS

Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

MYELODYSPLASTIC NEOPLASMS

Get alerted when new MYELODYSPLASTIC NEOPLASMS trials appear

New hope for tough blood cancers: experimental drug JNJ-90189892 enters human testing